Dr Reddys Laboratories (RDY) Profit After Tax (2009 - 2026)

Dr Reddys Laboratories has reported Profit After Tax for 18 years, with the latest figure at $45.9 million in Q2 2026.

• On a quarterly basis, Profit After Tax fell 72.12% year-over-year to $45.9 million in Q2 2026; TTM through Jun 2026 was $170.7 billion, a 87.36% increase from a year earlier, with the FY2026 full-year figure at $452.0 million, down 99.87% from the prior year.
• Profit After Tax was $45.9 million for Q2 2026 at Dr Reddys Laboratories, down from $80.2 billion in the prior quarter.
• The five-year high for Profit After Tax was $90.5 billion in Q1 2025, with the low at $20.2 million in Q1 2022.
• Average Profit After Tax over 5 years is $14.6 billion, with a median of $178.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Profit After Tax plunged 73.76% in 2022, then soared 50144.4% in 2025.
• Over 5 years, Profit After Tax stood at $117.0 million in 2022, then soared by 77.24% to $207.4 million in 2023, then climbed by 6.91% to $221.7 million in 2024, then jumped by 40592.98% to $90.2 billion in 2025, then slumped by 99.95% to $45.9 million in 2026.
• The last three Profit After Tax figures came in at $45.9 million (Q2 2026), $80.2 billion (Q1 2026), and $90.2 billion (Q4 2025), per Business Quant data.